TBET — Tibet Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Tibet Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | 2010 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 2.71 | 4.08 | 7.58 |
Net Total Accounts Receivable | |||
Net Total Receivables | 3.08 | 4.71 | 12.4 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 7.22 | 10.2 | 21.1 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 7.23 | 6.55 | 6.17 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 16 | 18 | 28.2 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Total Current Liabilities | 2.34 | 3.83 | 4.71 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 5.91 | 7.42 | 4.71 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 10.1 | 10.5 | 23.5 |
Total Liabilities & Shareholders' Equity | 16 | 18 | 28.2 |
Total Common Shares Outstanding |